Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma.
Liu Z, Poiret T, Persson O, Meng Q, Rane L, Bartek J Jr, Karbach J, Altmannsberger HM, Illies C, Luo X, Harvey-Peredo I, Jäger E, Dodoo E, Maeurer M. Liu Z, et al. Among authors: maeurer m. Cancer Immunol Immunother. 2018 Feb;67(2):237-246. doi: 10.1007/s00262-017-2066-z. Epub 2017 Oct 20. Cancer Immunol Immunother. 2018. PMID: 29058035 Free PMC article.
Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.
Poiret T, Axelsson-Robertson R, Remberger M, Luo XH, Rao M, Nagchowdhury A, Von Landenberg A, Ernberg I, Ringden O, Maeurer M. Poiret T, et al. Among authors: maeurer m. Front Immunol. 2018 Apr 10;9:760. doi: 10.3389/fimmu.2018.00760. eCollection 2018. Front Immunol. 2018. PMID: 29692783 Free PMC article.
Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.
Zhenjiang L, Rao M, Luo X, Valentini D, von Landenberg A, Meng Q, Sinclair G, Hoffmann N, Karbach J, Altmannsberger HM, Jäger E, Peredo IH, Dodoo E, Maeurer M. Zhenjiang L, et al. Among authors: maeurer m. EBioMedicine. 2018 Jul;33:49-56. doi: 10.1016/j.ebiom.2018.06.014. Epub 2018 Jun 29. EBioMedicine. 2018. PMID: 30049387 Free PMC article.
Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q, Liu Z, Rangelova E, Poiret T, Ambati A, Rane L, Xie S, Verbeke C, Dodoo E, Del Chiaro M, Löhr M, Segersvärd R, Maeurer MJ. Meng Q, et al. Among authors: maeurer mj. J Immunother. 2016 Feb-Mar;39(2):81-9. doi: 10.1097/CJI.0000000000000111. J Immunother. 2016. PMID: 26849077
Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.
Liu Z, Rao M, Poiret T, Nava S, Meng Q, von Landenberg A, Bartek J Jr, Xie S, Sinclair G, Peredo I, Dodoo E, Maeurer M. Liu Z, et al. Among authors: maeurer m. Oncotarget. 2017 Aug 16;8(46):80208-80222. doi: 10.18632/oncotarget.20303. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113296 Free PMC article.
Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses.
Meng Q, Valentini D, Rao M, Liu Z, Xie S, Morgell A, Dodoo E, Löhr M, Rangelova E, Del Chiaro M, Ernberg I, Maeurer M. Meng Q, et al. Among authors: maeurer m. Oncotarget. 2018 Apr 27;9(32):22451-22459. doi: 10.18632/oncotarget.25121. eCollection 2018 Apr 27. Oncotarget. 2018. PMID: 29854291 Free PMC article.
329 results